Effect of drug therapy on net cholesterol efflux capacity of HDL-enriched serum in rheumatoid arthritis

BACKGROUND: Patients with rheumatoid arthritis (RA) have increased coronary heart disease (CHD) risk. Some RA therapies may modify this risk, but underlying mechanisms are unclear. HDL’s cholesterol efflux capacity is associated with reduced CHD risk in non-RA populations; however, inflammation may...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Arthritis Rheumatol
Päätekijät: Ormseth, Michelle J., Yancey, Patricia G., Solus, Joseph F., Bridges, S. Louis, Curtis, Jeffrey R., Linton, MacRae F., Fazio, Sergio, Davies, Sean S., Roberts, L. Jackson, Vickers, Kasey C., Kon, Valentina, Stein, C. Michael
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5001900/
https://ncbi.nlm.nih.gov/pubmed/26991245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39675
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia